Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease

Documenti analoghi

• Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
  di: Runqi Wang, et al.
  Pubblicazione: (2026)
• Letter: Putting Crohn's Risk Prediction to Work in Perianal Fistula—Calibration, Thresholds, and Transport
  di: Emmanuel Pio Pastore
  Pubblicazione: (2025)
• Editorial: Upadacitinib in Perianal Crohn's Disease
  di: Manjeet Kumar Goyal, et al.
  Pubblicazione: (2026)
• Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula
  di: Alyssa M. Parian, et al.
  Pubblicazione: (2025)
• Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply
  di: Lichao Qiao, et al.
  Pubblicazione: (2025)